Related references
Note: Only part of the references are listed.JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells
Martin Laschak et al.
BMC CANCER (2012)
Anticancer Prodrugs: An Overview of Major Strategies and Recent Developments
Silvia Arpicco et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Glutathione Transferases as Targets for Cancer Therapy
Paolo Ruzza et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Sulphonamide-based bombesin prodrug analogues for glutathione transferase, useful in targeted cancer chemotherapy
I. Axarli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs
Harinath Chakrapani et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Glutathione Transferase: New Model for Glutathione Activation
Daniel F. A. R. Dourado et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells
Tanyel Kiziltepe et al.
BLOOD (2007)
Human glutathione transferases catalyzing the bioactivation of anticancer thiopurine prodrugs
Birgitta I. Eklund et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Divergent activities of human glutathione transferases in the bioactivation of azathioprine
Birgitta I. Eklund et al.
MOLECULAR PHARMACOLOGY (2006)
New crystal structures of human glutathione transferase A1-1 shed light on glutathione binding and the conformation of the C-terminal helix
E Grahn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Multi-institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer
JJ Kavanagh et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug
VJ Findlay et al.
MOLECULAR PHARMACOLOGY (2004)
Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen
S Gunnarsdottir et al.
DRUG METABOLISM AND DISPOSITION (2004)
Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer
C Sweeney et al.
TOXICOLOGY (2002)
Functional divergence in the glutathione transferase superfamily in plants -: Identification of two classes with putative functions in redox homeostasis in Arabidopsis thaliana
DP Dixon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Novel glutathione-dependent thiopurine prodrugs: Evidence for enhanced cytotoxicity in tumor cells and for decreased bone marrow toxicity in mice
S Gunnarsdottir et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Plant glutathione transferases
David P. Dixon et al.
GENOME BIOLOGY (2002)
Identification of a novel class of insect glutathione S-transferases involved in resistance to DDT in the malaria vector Anopheles gambiae
H Ranson et al.
BIOCHEMICAL JOURNAL (2001)
Glutathione conjugation as a bioactivation reaction
PJ van Bladeren
CHEMICO-BIOLOGICAL INTERACTIONS (2000)
Identification, characterization, and crystal structure of the omega class glutathione transferases
PG Board et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Cellular response to a glutathione S-transferase P1-1 activated prodrug
LA Rosario et al.
MOLECULAR PHARMACOLOGY (2000)
Share Paper
